Your browser doesn't support javascript.
loading
Switch to subcutaneous infliximab during the SARS-CoV-2 pandemic: preliminary results
Argüelles-Arias, Federico; Fernández Álvarez, Paula; Castro Laria, Luisa; Maldonado Pérez, Belén; Belvis Jiménez, María; Merino-Bohórquez, Vicente; Caunedo Álvarez, Ángel; Calleja Hernández, Miguel Ángel.
Affiliation
  • Argüelles-Arias, Federico; Hospital Universitario VirgenMacarena. Seville. Spain
  • Fernández Álvarez, Paula; Hospital Universitario VirgenMacarena. Seville. Spain
  • Castro Laria, Luisa; Hospital Universitario VirgenMacarena. Seville. Spain
  • Maldonado Pérez, Belén; Hospital Universitario VirgenMacarena. Seville. Spain
  • Belvis Jiménez, María; Hospital Universitario VirgenMacarena. Seville. Spain
  • Merino-Bohórquez, Vicente; Hospital Universitario VirgenMacarena. Seville. Spain
  • Caunedo Álvarez, Ángel; Hospital Universitario VirgenMacarena. Seville. Spain
  • Calleja Hernández, Miguel Ángel; Hospital Universitario VirgenMacarena. Seville. Spain
Rev. esp. enferm. dig ; 114(2): 118-119, febrero 2022. tab
Article in En | IBECS | ID: ibc-205559
Responsible library: ES1.1
Localization: ES15.1 - BNCS
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
Search on Google

Full text: 1 Collection: 06-national / ES Database: IBECS Main subject: Gastrointestinal Agents / Inflammatory Bowel Diseases / Coronavirus / Drug Substitution Limits: Humans Language: En Journal: Rev. esp. enferm. dig Year: 2022 Document type: Article
Fulltext
Add to My VHL
Print
XML
Search on Google

Full text: 1 Collection: 06-national / ES Database: IBECS Main subject: Gastrointestinal Agents / Inflammatory Bowel Diseases / Coronavirus / Drug Substitution Limits: Humans Language: En Journal: Rev. esp. enferm. dig Year: 2022 Document type: Article